Transparency

According to the requirements of the FSA (Voluntary Self-Regulation for the Pharmaceutical Industry), we as a congress agency are obliged to inform potential participants of congresses in advance of the event about the scope and conditions of support for the pharmaceutical industry. We are happy to fulfill this obligation and inform you about the level of sponsorship from the companies involved and from companies that voluntarily wish to publish.

The content of DGHM 2025 will be product- and service-neutral. We confirm that the scientific management and speakers will disclose any potential conflicts of interest to participants.

FSA-Liste